American Shared Hospital Services Reports Third Quarter and Nine-Month 2026 Financial Results

Amadeus IT Group reported a 3.7% revenue increase to EUR 5.075 billion for the first nine months of fiscal 2026. Net income fell slightly to EUR 1.081 billion, while adjusted profit rose to EUR 1.147 billion. CEO Luis Maroto expects 2026 outlook to be met, likely at the lower end, due to Middle East impacts.

American Shared Hospital Services (NYSE American: AMS) reported a Q2 2026 net loss of $514,000, or $0.07 per diluted share, widening from a $280,000 loss a year earlier, despite revenue rising 19.2% to $8.43 million. Direct patient services drove growth, while gross profit and operating loss worsened. Cash rose to $6.511 million at June 30, 2026, and the company later arranged financing with Fifth Third Bank.

American Shared Hospital Services (AMS) reported Q2 2026 earnings call highlights including 19% year-over-year revenue growth driven by direct patient services, higher international Gamma Knife volumes, and improving proton beam performance. Proton beam revenue rose 22% to about $2.3M in the quarter and $4.3M for six months. Reported results were impacted by $285k legal costs and a $909k credit-loss allowance. Cash equivalents and restricted cash were about $6.8M.

American Shared Hospital Services (NYSE: AMS) reported Q2 2026 revenue of $8.43M and $15.51M for the first half, up from $7.07M and $13.18M a year earlier, driven by direct patient services and higher PBRT and Gamma Knife volumes. The company posted net losses of $0.51M in Q2 and $1.13M for six months and disclosed substantial doubt about its going concern due to covenant breaches and debt default notices.

American Shared Hospital Services reported Q2 2026 revenue of $8.4 million, up 19.2% year over year and above the $7.56 million forecast. Adjusted EPS was a loss of $0.07 versus an expected loss of $0.02. Direct patient services rose to $4.9 million and proton beam revenue to about $2.3 million. Cash and equivalents were $6.8 million; management discussed refinancing debt due in 2027.

American Shared Hospital Services (AMEX: AMS) reported Q2 2026 revenue of $8.4 million, up 19% year over year. Direct patient services rose about 40% to $4.9 million, while Proton Beam Radiation Therapy revenue increased 22% to about $2.3 million. Adjusted EBITDA fell to about $1.3 million from $1.7 million. Cash increased to $6.8 million by quarter end.